223 related articles for article (PubMed ID: 23089600)
1. Comparative solution equilibrium studies of anticancer gallium(III) complexes of 8-hydroxyquinoline and hydroxy(thio)pyrone ligands.
Enyedy ÉA; Dömötör O; Varga E; Kiss T; Trondl R; Hartinger CG; Keppler BK
J Inorg Biochem; 2012 Dec; 117():189-97. PubMed ID: 23089600
[TBL] [Abstract][Full Text] [Related]
2. Solution equilibria of anticancer ruthenium(II)-(η(6)-p-cymene)-hydroxy(thio)pyr(id)one complexes: impact of sulfur vs. oxygen donor systems on the speciation and bioactivity.
Enyedy EA; Sija E; Jakusch T; Hartinger CG; Kandioller W; Keppler BK; Kiss T
J Inorg Biochem; 2013 Oct; 127():161-8. PubMed ID: 23721887
[TBL] [Abstract][Full Text] [Related]
3. Structural and photophysical studies on gallium(III) 8-hydroxyquinoline-5-sulfonates. Does excited state decay involve ligand photolabilisation?
Ramos ML; de Sousa AR; Justino LL; Fonseca SM; Geraldes CF; Burrows HD
Dalton Trans; 2013 Mar; 42(10):3682-94. PubMed ID: 23299787
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the anticancer gallium(III) complexes of 8-hydroxyquinoline and maltol with human serum proteins.
Enyedy ÉA; Dömötör O; Bali K; Hetényi A; Tuccinardi T; Keppler BK
J Biol Inorg Chem; 2015 Jan; 20(1):77-88. PubMed ID: 25398250
[TBL] [Abstract][Full Text] [Related]
5. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
[TBL] [Abstract][Full Text] [Related]
6. Comparative solution equilibrium studies of antitumor ruthenium(η
Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
[TBL] [Abstract][Full Text] [Related]
7. NMR, DFT and luminescence studies of the complexation of Al(III) with 8-hydroxyquinoline-5-sulfonate.
Ramos ML; Justino LL; Salvador AI; de Sousa AR; Abreu PE; Fonseca SM; Burrows HD
Dalton Trans; 2012 Oct; 41(40):12478-89. PubMed ID: 22955198
[TBL] [Abstract][Full Text] [Related]
8. Experimental and theoretical approach of photophysical properties of lanthanum(III) and erbium(III) complexes of tris(methoxymethyl)-5-oxine podant.
Akbar R; Baral M; Kanungo BK
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():365-76. PubMed ID: 24747862
[TBL] [Abstract][Full Text] [Related]
9. Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects.
Timerbaev AR
Metallomics; 2009; 1(3):193-8. PubMed ID: 21305117
[TBL] [Abstract][Full Text] [Related]
10. Solution speciation and human serum protein binding of indium(III) complexes of 8-hydroxyquinoline, deferiprone and maltol.
Dömötör O; Keppler BK; Enyedy ÉA
J Biol Inorg Chem; 2022 Apr; 27(3):315-328. PubMed ID: 35243522
[TBL] [Abstract][Full Text] [Related]
11. NMR, DFT and luminescence studies of the complexation of Zn(II) with 8-hydroxyquinoline-5-sulfonate.
Luísa Ramos M; Justino LL; Branco A; Duarte CM; Abreu PE; Fonseca SM; Burrows HD
Dalton Trans; 2011 Nov; 40(44):11732-41. PubMed ID: 21964543
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic and pH-metric studies on the complexation of a novel tripodal amine-phenol ligand towards Al(III), Ga(III) and In(III).
Sahoo SK; Bera RK; Kanungo BK; Baral M
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Apr; 89():322-8. PubMed ID: 22286053
[TBL] [Abstract][Full Text] [Related]
13. Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium.
Šimeček J; Schulz M; Notni J; Plutnar J; Kubíček V; Havlíčková J; Hermann P
Inorg Chem; 2012 Jan; 51(1):577-90. PubMed ID: 22221285
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and equilibria of the interaction of 8-hydroxyquinoline with gallium(III) in water and sodium dodecyl sulfate solution.
Biver T; Ghezzi L; Malvaldi V; Secco F; Tiné MR; Venturini M
J Phys Chem B; 2009 Feb; 113(6):1598-606. PubMed ID: 19146470
[TBL] [Abstract][Full Text] [Related]
15. Oxocomplexes of Mo(VI) and W(VI) with 8-hydroxyquinoline-5-sulfonate in solution: structural studies and the effect of the metal ion on the photophysical behaviour.
Ramos ML; Justino LL; Abreu PE; Fonseca SM; Burrows HD
Dalton Trans; 2015 Nov; 44(44):19076-89. PubMed ID: 26498366
[TBL] [Abstract][Full Text] [Related]
16. Complex formation between Ru(η(6)-p-cym)(H2O)3]2+ and (O,O) donor ligands with biological relevance in aqueous solution.
Bíró L; Farkas E; Buglyó P
Dalton Trans; 2010 Nov; 39(42):10272-8. PubMed ID: 20922244
[TBL] [Abstract][Full Text] [Related]
17. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
[TBL] [Abstract][Full Text] [Related]
18. Antioxidation and DNA-binding properties of binuclear Er(III) complexes with Schiff-base ligands derived from 8-hydroxyquinoline-2-carboxaldehyde and four aroylhydrazines.
Liu YC; Yang ZY
J Biochem; 2010 Mar; 147(3):381-91. PubMed ID: 19910309
[TBL] [Abstract][Full Text] [Related]
19. Gallium(III) chelates of mixed phosphonate-carboxylate triazamacrocyclic ligands relevant to nuclear medicine: Structural, stability and in vivo studies.
Prata MIM; André JP; Kovács Z; Takács AI; Tircsó G; Tóth I; Geraldes CFGC
J Inorg Biochem; 2017 Dec; 177():8-16. PubMed ID: 28918355
[TBL] [Abstract][Full Text] [Related]
20. Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins.
Rudnev AV; Foteeva LS; Kowol C; Berger R; Jakupec MA; Arion VB; Timerbaev AR; Keppler BK
J Inorg Biochem; 2006 Nov; 100(11):1819-26. PubMed ID: 16938349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
